- Home
- RIOT vs MLTX Comparison
RIOT vs MLTX Comparison
Compare RIOT & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIOT
- MLTX
- Stock Information
- Founded
- RIOT 2000
- MLTX 2021
- Country
- RIOT United States
- MLTX Switzerland
- Employees
- RIOT N/A
- MLTX N/A
- Industry
- RIOT Retail: Computer Software & Peripheral Equipment
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- RIOT Technology
- MLTX Health Care
- Exchange
- RIOT Nasdaq
- MLTX Nasdaq
- Market Cap
- RIOT 2.8B
- MLTX 2.5B
- IPO Year
- RIOT N/A
- MLTX N/A
- Fundamental
- Price
- RIOT $9.56
- MLTX $43.50
- Analyst Decision
- RIOT Strong Buy
- MLTX Strong Buy
- Analyst Count
- RIOT 10
- MLTX 8
- Target Price
- RIOT $17.06
- MLTX $77.71
- AVG Volume (30 Days)
- RIOT 39.8M
- MLTX 676.4K
- Earning Date
- RIOT 07-30-2025
- MLTX 08-06-2025
- Dividend Yield
- RIOT N/A
- MLTX N/A
- EPS Growth
- RIOT N/A
- MLTX N/A
- EPS
- RIOT N/A
- MLTX N/A
- Revenue
- RIOT $458,749,000.00
- MLTX N/A
- Revenue This Year
- RIOT $74.42
- MLTX $103.42
- Revenue Next Year
- RIOT $12.12
- MLTX N/A
- P/E Ratio
- RIOT N/A
- MLTX N/A
- Revenue Growth
- RIOT 59.99
- MLTX N/A
- 52 Week Low
- RIOT $6.19
- MLTX $31.42
- 52 Week High
- RIOT $15.87
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- RIOT 52.83
- MLTX 52.69
- Support Level
- RIOT $9.36
- MLTX $42.22
- Resistance Level
- RIOT $10.87
- MLTX $44.20
- Average True Range (ATR)
- RIOT 0.65
- MLTX 2.11
- MACD
- RIOT -0.03
- MLTX -0.36
- Stochastic Oscillator
- RIOT 54.48
- MLTX 32.18
About RIOT Riot Platforms Inc.
Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining and Engineering. The Bitcoin Mining segment generates revenue from the Bitcoin the Company earns through its Bitcoin Mining activities. The Engineering segment generates revenue through customer contracts for custom engineered electrical products. It generates the majority of its revenue from the Bitcoin Mining segment.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.